nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—HRH3—attention deficit hyperactivity disorder	0.179	0.225	CbGaD
Mirtazapine—ADRA2C—attention deficit hyperactivity disorder	0.163	0.205	CbGaD
Mirtazapine—DRD4—attention deficit hyperactivity disorder	0.0885	0.111	CbGaD
Mirtazapine—DRD3—attention deficit hyperactivity disorder	0.0764	0.0961	CbGaD
Mirtazapine—SLC6A3—attention deficit hyperactivity disorder	0.071	0.0894	CbGaD
Mirtazapine—ADRA2A—attention deficit hyperactivity disorder	0.0696	0.0877	CbGaD
Mirtazapine—SLC6A4—attention deficit hyperactivity disorder	0.0531	0.0669	CbGaD
Mirtazapine—DRD2—attention deficit hyperactivity disorder	0.0528	0.0665	CbGaD
Mirtazapine—HTR2A—attention deficit hyperactivity disorder	0.0408	0.0514	CbGaD
Mirtazapine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00453	0.0767	CbGeAlD
Mirtazapine—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00437	0.0739	CbGeAlD
Mirtazapine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00272	0.0461	CbGeAlD
Mirtazapine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00241	0.0408	CbGeAlD
Mirtazapine—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00232	0.0393	CbGeAlD
Mirtazapine—HRH3—forebrain—attention deficit hyperactivity disorder	0.00174	0.0295	CbGeAlD
Mirtazapine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00145	0.0245	CbGeAlD
Mirtazapine—OPRK1—forebrain—attention deficit hyperactivity disorder	0.00108	0.0182	CbGeAlD
Mirtazapine—HRH3—nervous system—attention deficit hyperactivity disorder	0.000946	0.016	CbGeAlD
Mirtazapine—HRH3—central nervous system—attention deficit hyperactivity disorder	0.000911	0.0154	CbGeAlD
Mirtazapine—HRH3—cerebellum—attention deficit hyperactivity disorder	0.000891	0.0151	CbGeAlD
Mirtazapine—HTR3A—forebrain—attention deficit hyperactivity disorder	0.000836	0.0141	CbGeAlD
Mirtazapine—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.000808	0.227	CrCbGaD
Mirtazapine—HRH3—brain—attention deficit hyperactivity disorder	0.000723	0.0122	CbGeAlD
Mirtazapine—DRD4—brain—attention deficit hyperactivity disorder	0.000713	0.0121	CbGeAlD
Mirtazapine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.000695	0.0118	CbGeAlD
Mirtazapine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000672	0.0114	CbGeAlD
Mirtazapine—ADRB1—forebrain—attention deficit hyperactivity disorder	0.00066	0.0112	CbGeAlD
Mirtazapine—DRD3—nervous system—attention deficit hyperactivity disorder	0.000656	0.0111	CbGeAlD
Mirtazapine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.000637	0.0108	CbGeAlD
Mirtazapine—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000632	0.0107	CbGeAlD
Mirtazapine—HTR2B—forebrain—attention deficit hyperactivity disorder	0.000631	0.0107	CbGeAlD
Mirtazapine—Epinastine—ADRA2A—attention deficit hyperactivity disorder	0.000596	0.168	CrCbGaD
Mirtazapine—OPRK1—nervous system—attention deficit hyperactivity disorder	0.000585	0.0099	CbGeAlD
Mirtazapine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000566	0.00958	CbGeAlD
Mirtazapine—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.000563	0.00953	CbGeAlD
Mirtazapine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.000561	0.0095	CbGeAlD
Mirtazapine—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.000558	0.00944	CbGeAlD
Mirtazapine—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.00055	0.00932	CbGeAlD
Mirtazapine—HTR7—forebrain—attention deficit hyperactivity disorder	0.000541	0.00915	CbGeAlD
Mirtazapine—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.000534	0.00904	CbGeAlD
Mirtazapine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000522	0.00883	CbGeAlD
Mirtazapine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000511	0.00866	CbGeAlD
Mirtazapine—DRD3—brain—attention deficit hyperactivity disorder	0.000501	0.00849	CbGeAlD
Mirtazapine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000478	0.0081	CbGeAlD
Mirtazapine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.000459	0.00777	CbGeAlD
Mirtazapine—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000457	0.00774	CbGeAlD
Mirtazapine—HTR3A—nervous system—attention deficit hyperactivity disorder	0.000454	0.00768	CbGeAlD
Mirtazapine—OPRK1—brain—attention deficit hyperactivity disorder	0.000447	0.00757	CbGeAlD
Mirtazapine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000444	0.00752	CbGeAlD
Mirtazapine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000441	0.00747	CbGeAlD
Mirtazapine—HTR3A—central nervous system—attention deficit hyperactivity disorder	0.000437	0.0074	CbGeAlD
Mirtazapine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000421	0.00712	CbGeAlD
Mirtazapine—HRH1—forebrain—attention deficit hyperactivity disorder	0.000404	0.00684	CbGeAlD
Mirtazapine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000397	0.00671	CbGeAlD
Mirtazapine—Mianserin—DRD3—attention deficit hyperactivity disorder	0.000378	0.106	CrCbGaD
Mirtazapine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000378	0.00639	CbGeAlD
Mirtazapine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000374	0.00633	CbGeAlD
Mirtazapine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000365	0.00618	CbGeAlD
Mirtazapine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000363	0.00615	CbGeAlD
Mirtazapine—ADRB1—nervous system—attention deficit hyperactivity disorder	0.000358	0.00606	CbGeAlD
Mirtazapine—HTR7—midbrain—attention deficit hyperactivity disorder	0.000357	0.00605	CbGeAlD
Mirtazapine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000355	0.00601	CbGeAlD
Mirtazapine—Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.000352	0.099	CrCbGaD
Mirtazapine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000351	0.00595	CbGeAlD
Mirtazapine—Epinastine—HTR2A—attention deficit hyperactivity disorder	0.000349	0.0983	CrCbGaD
Mirtazapine—HTR3A—brain—attention deficit hyperactivity disorder	0.000347	0.00587	CbGeAlD
Mirtazapine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000346	0.00586	CbGeAlD
Mirtazapine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000346	0.00586	CbGeAlD
Mirtazapine—Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.000345	0.097	CrCbGaD
Mirtazapine—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.000345	0.00584	CbGeAlD
Mirtazapine—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000343	0.0058	CbGeAlD
Mirtazapine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000338	0.00572	CbGeAlD
Mirtazapine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000337	0.00571	CbGeAlD
Mirtazapine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000333	0.00564	CbGeAlD
Mirtazapine—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.00033	0.00559	CbGeAlD
Mirtazapine—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000328	0.00556	CbGeAlD
Mirtazapine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000307	0.0052	CbGeAlD
Mirtazapine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000307	0.0052	CbGeAlD
Mirtazapine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000305	0.00516	CbGeAlD
Mirtazapine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000296	0.00501	CbGeAlD
Mirtazapine—HTR7—nervous system—attention deficit hyperactivity disorder	0.000294	0.00497	CbGeAlD
Mirtazapine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000293	0.00496	CbGeAlD
Mirtazapine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000289	0.00489	CbGeAlD
Mirtazapine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000289	0.00489	CbGeAlD
Mirtazapine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000285	0.00483	CbGeAlD
Mirtazapine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000283	0.00479	CbGeAlD
Mirtazapine—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000283	0.00478	CbGeAlD
Mirtazapine—HTR2C—brain—attention deficit hyperactivity disorder	0.000279	0.00472	CbGeAlD
Mirtazapine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000278	0.0047	CbGeAlD
Mirtazapine—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000276	0.00468	CbGeAlD
Mirtazapine—ADRB1—brain—attention deficit hyperactivity disorder	0.000274	0.00463	CbGeAlD
Mirtazapine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000273	0.00462	CbGeAlD
Mirtazapine—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.00027	0.00457	CbGeAlD
Mirtazapine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000267	0.00452	CbGeAlD
Mirtazapine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000266	0.00451	CbGeAlD
Mirtazapine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000264	0.00448	CbGeAlD
Mirtazapine—Mianserin—SLC6A4—attention deficit hyperactivity disorder	0.000263	0.074	CrCbGaD
Mirtazapine—HTR2B—brain—attention deficit hyperactivity disorder	0.000262	0.00444	CbGeAlD
Mirtazapine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000262	0.00443	CbGeAlD
Mirtazapine—Mianserin—DRD2—attention deficit hyperactivity disorder	0.000262	0.0736	CrCbGaD
Mirtazapine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000261	0.00442	CbGeAlD
Mirtazapine—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.00026	0.0044	CbGeAlD
Mirtazapine—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000254	0.0043	CbGeAlD
Mirtazapine—HTR1A—brain—attention deficit hyperactivity disorder	0.000235	0.00397	CbGeAlD
Mirtazapine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000233	0.00394	CbGeAlD
Mirtazapine—HTR7—brain—attention deficit hyperactivity disorder	0.000224	0.0038	CbGeAlD
Mirtazapine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000223	0.00377	CbGeAlD
Mirtazapine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000219	0.00371	CbGeAlD
Mirtazapine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000216	0.00366	CbGeAlD
Mirtazapine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000215	0.00364	CbGeAlD
Mirtazapine—DRD2—brain—attention deficit hyperactivity disorder	0.000212	0.00359	CbGeAlD
Mirtazapine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000211	0.00357	CbGeAlD
Mirtazapine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000207	0.00351	CbGeAlD
Mirtazapine—ADRA2C—brain—attention deficit hyperactivity disorder	0.000206	0.00349	CbGeAlD
Mirtazapine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000203	0.00343	CbGeAlD
Mirtazapine—Mianserin—HTR2A—attention deficit hyperactivity disorder	0.000202	0.0569	CrCbGaD
Mirtazapine—CYP2C8—brain—attention deficit hyperactivity disorder	0.000191	0.00324	CbGeAlD
Mirtazapine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000183	0.0031	CbGeAlD
Mirtazapine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000176	0.00298	CbGeAlD
Mirtazapine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000172	0.00292	CbGeAlD
Mirtazapine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000169	0.00287	CbGeAlD
Mirtazapine—HRH1—brain—attention deficit hyperactivity disorder	0.000168	0.00284	CbGeAlD
Mirtazapine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000167	0.00282	CbGeAlD
Mirtazapine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000165	0.00279	CbGeAlD
Mirtazapine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000163	0.00276	CbGeAlD
Mirtazapine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000161	0.00272	CbGeAlD
Mirtazapine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000157	0.00266	CbGeAlD
Mirtazapine—HTR2A—brain—attention deficit hyperactivity disorder	0.00014	0.00237	CbGeAlD
Mirtazapine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000127	0.00216	CbGeAlD
Mirtazapine—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.05e-05	7.36e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.05e-05	7.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.05e-05	7.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.04e-05	7.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	1.04e-05	7.3e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.04e-05	7.3e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.04e-05	7.28e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.04e-05	7.26e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.04e-05	7.26e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.04e-05	7.25e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.03e-05	7.24e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.03e-05	7.23e-05	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.03e-05	7.23e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.03e-05	7.22e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.03e-05	7.19e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.02e-05	7.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.02e-05	7.16e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.02e-05	7.14e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.02e-05	7.13e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.02e-05	7.13e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.02e-05	7.11e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.01e-05	7.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.01e-05	7.07e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.01e-05	7.05e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.01e-05	7.04e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1e-05	7.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1e-05	7.02e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	9.99e-06	6.99e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.91e-06	6.93e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.89e-06	6.92e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	9.87e-06	6.91e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.83e-06	6.88e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	9.75e-06	6.82e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.73e-06	6.81e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.72e-06	6.8e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.7e-06	6.79e-05	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.62e-06	6.73e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.58e-06	6.7e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.56e-06	6.69e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.47e-06	6.63e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.45e-06	6.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	9.44e-06	6.61e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.43e-06	6.6e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.41e-06	6.59e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	9.4e-06	6.58e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.39e-06	6.57e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.38e-06	6.57e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.37e-06	6.56e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.3e-06	6.51e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.22e-06	6.46e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.19e-06	6.43e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.17e-06	6.42e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	9.17e-06	6.42e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.05e-06	6.33e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.04e-06	6.32e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.02e-06	6.31e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.01e-06	6.31e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.97e-06	6.28e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.8e-06	6.16e-05	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.76e-06	6.13e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.75e-06	6.13e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.73e-06	6.11e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.73e-06	6.11e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.66e-06	6.06e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	8.62e-06	6.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.62e-06	6.03e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.6e-06	6.02e-05	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.57e-06	6e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.54e-06	5.98e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.5e-06	5.95e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.48e-06	5.94e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	8.48e-06	5.93e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.41e-06	5.89e-05	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.38e-06	5.87e-05	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.34e-06	5.83e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.29e-06	5.8e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.24e-06	5.77e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.13e-06	5.69e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.11e-06	5.68e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.07e-06	5.65e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.06e-06	5.64e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.06e-06	5.64e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.01e-06	5.6e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.96e-06	5.57e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.92e-06	5.54e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.92e-06	5.54e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.91e-06	5.53e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.88e-06	5.52e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.88e-06	5.52e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.84e-06	5.49e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.79e-06	5.45e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.78e-06	5.45e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.77e-06	5.44e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.66e-06	5.36e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.63e-06	5.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.63e-06	5.34e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.61e-06	5.33e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.57e-06	5.3e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.5e-06	5.25e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.42e-06	5.19e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.37e-06	5.15e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.36e-06	5.15e-05	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.36e-06	5.15e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.33e-06	5.13e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.29e-06	5.1e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.29e-06	5.1e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.26e-06	5.08e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.22e-06	5.06e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.2e-06	5.04e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.14e-06	4.99e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.1e-06	4.97e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.09e-06	4.96e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.09e-06	4.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.09e-06	4.96e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.06e-06	4.94e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.05e-06	4.93e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.98e-06	4.88e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.94e-06	4.86e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.92e-06	4.84e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.89e-06	4.82e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.89e-06	4.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.89e-06	4.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.87e-06	4.81e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.86e-06	4.8e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	6.84e-06	4.79e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.84e-06	4.79e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.81e-06	4.77e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	6.8e-06	4.76e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.8e-06	4.76e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.75e-06	4.72e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	6.73e-06	4.71e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.71e-06	4.7e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.68e-06	4.68e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.67e-06	4.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.67e-06	4.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.59e-06	4.61e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.56e-06	4.59e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.56e-06	4.59e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.44e-06	4.51e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.43e-06	4.5e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	6.43e-06	4.5e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.42e-06	4.49e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.39e-06	4.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	6.38e-06	4.47e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.33e-06	4.43e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.32e-06	4.42e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.26e-06	4.38e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.23e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.22e-06	4.35e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.21e-06	4.35e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.2e-06	4.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.2e-06	4.34e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.16e-06	4.31e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.13e-06	4.29e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.13e-06	4.29e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.12e-06	4.28e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.07e-06	4.25e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.05e-06	4.23e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.03e-06	4.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.01e-06	4.21e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6e-06	4.2e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.98e-06	4.19e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.95e-06	4.17e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.94e-06	4.16e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.9e-06	4.13e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.83e-06	4.08e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.81e-06	4.06e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.76e-06	4.03e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	5.61e-06	3.93e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.61e-06	3.93e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.58e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	5.57e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.57e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.55e-06	3.88e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.54e-06	3.88e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.53e-06	3.87e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	5.52e-06	3.87e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	5.52e-06	3.86e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	5.48e-06	3.83e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.47e-06	3.83e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.43e-06	3.8e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.42e-06	3.79e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.32e-06	3.72e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	5.22e-06	3.65e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.21e-06	3.64e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	5.18e-06	3.63e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.16e-06	3.61e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.14e-06	3.59e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.09e-06	3.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.05e-06	3.53e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	4.76e-06	3.33e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.76e-06	3.33e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.7e-06	3.29e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	4.68e-06	3.28e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.6e-06	3.22e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.5e-06	3.15e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.49e-06	3.14e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.47e-06	3.13e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.45e-06	3.11e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.35e-06	3.04e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.35e-06	3.04e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.27e-06	2.99e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.24e-06	2.96e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	4.14e-06	2.9e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	4.11e-06	2.88e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.99e-06	2.79e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.95e-06	2.76e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.88e-06	2.71e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.8e-06	2.66e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.8e-06	2.66e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	3.67e-06	2.57e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.67e-06	2.57e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.62e-06	2.53e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	3.61e-06	2.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.53e-06	2.47e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	3.4e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	3.38e-06	2.36e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	3.37e-06	2.36e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.36e-06	2.35e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	3.35e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.26e-06	2.28e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.25e-06	2.27e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.21e-06	2.25e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.08e-06	2.15e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.94e-06	2.06e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.93e-06	2.05e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	2.88e-06	2.02e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.86e-06	2e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.79e-06	1.96e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.78e-06	1.94e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	2.76e-06	1.93e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.73e-06	1.91e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.49e-06	1.74e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.44e-06	1.7e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.38e-06	1.67e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.37e-06	1.66e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.3e-06	1.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	2.24e-06	1.57e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.22e-06	1.56e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.21e-06	1.55e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.09e-06	1.46e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.06e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.05e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.01e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.87e-06	1.31e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	1.78e-06	1.24e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.46e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	1.45e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.24e-06	8.65e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	9.54e-07	6.68e-06	CbGpPWpGaD
